
TY  - JOUR
TI  - Posters
JO  - Journal of the European Academy of Dermatology and Venereology
VL  - 18
IS  - s2
SN  - 0926-9959
UR  - https://doi.org/10.1111/j.1468-3083.2004.01152.x
DO  - doi:10.1111/j.1468-3083.2004.01152.x
SP  - 193
EP  - 557
PY  - 2004
ER  - 

TY  - JOUR
AU  - Galloway, David
AU  - Danziger-Isakov, Lara
AU  - Goldschmidt, Monique
AU  - Hemmelgarn, Trina
AU  - Courter, Joshua
AU  - Nathan, Jaimie D.
AU  - Alonso, Maria
AU  - Tiao, Greg
AU  - Fei, Lin
AU  - Kocoshis, Samuel
TI  - Incidence of bloodstream infections in small bowel transplant recipients receiving selective decontamination of the digestive tract: A single-center experience
JO  - Pediatric Transplantation
JA  - Pediatr Transplantation
VL  - 19
IS  - 7
SN  - 1397-3142
UR  - https://doi.org/10.1111/petr.12583
DO  - doi:10.1111/petr.12583
SP  - 722
EP  - 729
KW  - pediatric transplantation
KW  - intestinal transplantation
KW  - infectious risk
PY  - 2015
AB  - Abstract Pediatric patients undergoing small bowel transplantation are susceptible to postoperative CLABSI. SDD directed against enteric microbes is a strategy for reducing CLABSI. We hypothesized that SDD reduces the frequency of CLABSI, infections outside the bloodstream, and allograft rejection during the first 30 days following transplant. A retrospective chart review of 38 pediatric small bowel transplant recipients at CCHMC from 2003 to 2011 was conducted. SDD antimicrobials were oral colistin, tobramycin, and amphotericin B. The incidence of CLABSI, infections outside the bloodstream, and rejection episodes were compared between study periods. The incidence of CLABSI did not differ between study periods (6.9 CLABSI vs. 4.6 CLABSI per 1000 catheter days; p = 0.727), but gram positives and Candida predominated in the first 30 days. Incidence of bacterial infections outside the bloodstream did not differ (p = 0.227). Rejection occurred more frequently during the first month following transplant (p = 0.302). SDD does not alter the incidence of CLABSI, bacterial infections outside the bloodstream, or allograft rejection in the immediate 30 days post-transplantation. However, SDD does influence CLABSI organism types (favoring gram positives and Candida) and Candidal infections outside the bloodstream.
ER  - 

TY  - JOUR
TI  - Abstracts of the 6th Cachexia Conference, Milan, Italy, December 8–10, 2011
JO  - Journal of Cachexia, Sarcopenia and Muscle
JA  - J Cachexia Sarcopenia Muscle
VL  - 2
IS  - 4
SN  - 2190-5991
UR  - https://doi.org/10.1007/s13539-011-0045-3
DO  - doi:10.1007/s13539-011-0045-3
SP  - 209
EP  - 261
PY  - 2011
ER  - 

TY  - JOUR
TI  - Abstracts 416–623
JO  - Hepatology
JA  - Hepatology
VL  - 50
IS  - S4
SN  - 0270-9139
UR  - https://doi.org/10.1002/hep.23302
DO  - doi:10.1002/hep.23302
SP  - 502A
EP  - 599A
PY  - 2009
ER  - 

TY  - JOUR
TI  - 6th Congress of the European College of Equine Internal Medicine
JO  - Journal of Veterinary Internal Medicine
JA  - J Vet Intern Med
VL  - 28
IS  - 2
SN  - 0891-6640
UR  - https://doi.org/10.1111/jvim.12326
DO  - doi:10.1111/jvim.12326
SP  - 696
EP  - 710
PY  - 2014
ER  - 

TY  - JOUR
TI  - Proceedings of the VI National Congress of Pharmacology October 2009 – Plenary Lectures
JO  - Autonomic and Autacoid Pharmacology
VL  - 30
IS  - 1
SN  - 1474-8665
UR  - https://doi.org/10.1111/j.1474-8673.2009.00451.x
DO  - doi:10.1111/j.1474-8673.2009.00451.x
SP  - 67
EP  - 95
PY  - 2010
ER  - 

TY  - JOUR
AU  - Jacobs, Heidi I.L.
AU  - Leritz, Elizabeth C.
AU  - Williams, Victoria J.
AU  - Van Boxtel, Martin P.J.
AU  - Elst, Wim van der
AU  - Jolles, Jelle
AU  - Verhey, Frans R.J.
AU  - McGlinchey, Regina E.
AU  - Milberg, William P.
AU  - Salat, David H.
TI  - Association between white matter microstructure, executive functions, and processing speed in older adults: The impact of vascular health
JO  - Human Brain Mapping
JA  - Hum. Brain Mapp.
VL  - 34
IS  - 1
SN  - 1065-9471
UR  - https://doi.org/10.1002/hbm.21412
DO  - doi:10.1002/hbm.21412
SP  - 77
EP  - 95
KW  - blood pressure
KW  - hypertension
KW  - white matter signal abnormalities
KW  - diffusion tensor imaging
KW  - aging
KW  - executive function
PY  - 2013
AB  - Abstract Cerebral white matter damage is not only a commonly reported consequence of healthy aging, but is also associated with cognitive decline and dementia. The aetiology of this damage is unclear; however, individuals with hypertension have a greater burden of white matter signal abnormalities (WMSA) on MR imaging than those without hypertension. It is therefore possible that elevated blood pressure (BP) impacts white matter tissue structure which in turn has a negative impact on cognition. However, little information exists about whether vascular health indexed by BP mediates the relationship between cognition and white matter tissue structure. We used diffusion tensor imaging to examine the impact of vascular health on regional associations between white matter integrity and cognition in healthy older adults spanning the normotensive to moderate?severe hypertensive BP range (43?87 years; N = 128). We examined how white matter structure was associated with performance on tests of two cognitive domains, executive functioning (EF) and processing speed (PS), and how patterns of regional associations were modified by BP and WMSA. Multiple linear regression and structural equation models demonstrated associations between tissue structure, EF and PS in frontal, temporal, parietal, and occipital white matter regions. Radial diffusivity was more prominently associated with performance than axial diffusivity. BP only minimally influenced the relationship between white matter integrity, EF and PS. However, WMSA volume had a major impact on neurocognitive associations. This suggests that, although BP and WMSA are causally related, these differential metrics of vascular health may act via independent pathways to influence brain structure, EF and PS. Hum Brain Mapp, 2013. ? 2011 Wiley Periodicals, Inc.
ER  - 

TY  - JOUR
TI  - 2016 ACVIM Forum Research Abstract Program
JO  - Journal of Veterinary Internal Medicine
JA  - J Vet Intern Med
VL  - 30
IS  - 4
SN  - 0891-6640
UR  - https://doi.org/10.1111/jvim.13952
DO  - doi:10.1111/jvim.13952
SP  - 1407
EP  - 1519
PY  - 2016
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Transplant International
JA  - Transpl Int
VL  - 29
IS  - S5
SN  - 0934-0874
UR  - https://doi.org/10.1111/tri.12867
DO  - doi:10.1111/tri.12867
SP  - 5
EP  - 16
PY  - 2016
ER  - 

TY  - JOUR
TI  - Abstracts for Poster Presentation
JO  - Journal of Gastroenterology and Hepatology
VL  - 22
IS  - s2
SN  - 0815-9319
UR  - https://doi.org/10.1111/j.1440-1746.2007.05194.x
DO  - doi:10.1111/j.1440-1746.2007.05194.x
SP  - A190
EP  - A219
PY  - 2007
ER  - 

TY  - JOUR
TI  - Abstracts of the IPITA-IXA-CTS 2015 Joint Congress November 15–19, 2015, Melbourne, Australia
JO  - Xenotransplantation
JA  - Xenotransplantation
VL  - 22
IS  - S1
SN  - 0908-665X
UR  - https://doi.org/10.1111/xen.12204
DO  - doi:10.1111/xen.12204
SP  - S2
EP  - S47
PY  - 2015
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - European Journal of Heart Failure
JA  - Eur J Heart Fail
VL  - 16
IS  - s1
SN  - 1388-9842
UR  - https://doi.org/10.1002/ejhf.77
DO  - doi:10.1002/ejhf.77
SP  - 1
EP  - 41
PY  - 2014
ER  - 

AU  - McArdle, Colin
AU  - Modlin, Irwin M.
AU  - Bornschein, Jon
AU  - Kidd, Mark
AU  - Mann, Gary N.
AU  - Bhatia, Shailender
AU  - Thompson, John L.
AU  - Clark, Matthew
AU  - Israel, Lincoln
AU  - Sugarbaker, Paul H.
AU  - Yan, Tristan D.
C7  - pp. 374-407
TI  - Rare Cancers
SN  - 9781405127837
UR  - https://doi.org/10.1002/9781444300147.ch15
DO  - doi:10.1002/9781444300147.ch15
SP  - 374-407
KW  - rare cancers
KW  - neuroendocrine tumors (NETs = carcinoids)
KW  - symptomatic therapy for carcinoid disease and SST analogs
KW  - hypergastrinemia-associated carcinoids
KW  - anorectal melanomas (ARM)
KW  - pseudomyxoma peritonei syndrome
KW  - perioperative intraperitoneal chemotherapy
PY  - 2014
AB  - Summary This chapter contains sections titled: Gastrointestinal carcinoids Anorectal melanoma Cancer of the anal canal Appendiceal epithelial neoplasms Diffuse malignant peritoneal mesothelioma References
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - The FEBS Journal
VL  - 274
IS  - s1
SN  - 9781405127837
UR  - https://doi.org/10.1111/j.0014-2956.2007.05861_3.x
DO  - doi:10.1111/j.0014-2956.2007.05861_3.x
SP  - 133
EP  - 220
PY  - 2007
ER  - 

TY  - JOUR
TI  - Abstracts TPS
JO  - Allergy
JA  - Allergy
VL  - 73
IS  - S105
SN  - 9781405127837
UR  - https://doi.org/10.1111/all.13539
DO  - doi:10.1111/all.13539
SP  - 370
EP  - 702
PY  - 2018
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Nephrology
VL  - 14
IS  - s1
SN  - 9781405127837
UR  - https://doi.org/10.1111/j.1440-1797.2009.01176.x
DO  - doi:10.1111/j.1440-1797.2009.01176.x
SP  - A1
EP  - A56
PY  - 2009
ER  - 

TY  - JOUR
TI  - Abstracts 200–407
JO  - Hepatology
JA  - Hepatology
VL  - 52
IS  - S1
SN  - 9781405127837
UR  - https://doi.org/10.1002/hep.23979
DO  - doi:10.1002/hep.23979
SP  - 422A
EP  - 522A
PY  - 2010
ER  - 

TY  - JOUR
AU  - Bugelski, Peter J
AU  - Martin, Pauline L
TI  - Concordance of preclinical and clinical pharmacology and toxicology of therapeutic monoclonal antibodies and fusion proteins: cell surface targets
JO  - British Journal of Pharmacology
VL  - 166
IS  - 3
SN  - 9781405127837
UR  - https://doi.org/10.1111/j.1476-5381.2011.01811.x
DO  - doi:10.1111/j.1476-5381.2011.01811.x
SP  - 823
EP  - 846
KW  - monoclonal antibody
KW  - biopharmaceutical
KW  - non-clinical safety
KW  - clinical safety
KW  - adverse effects
KW  - toxicology
KW  - surrogate
KW  - rodent
KW  - cynomolgus monkey
KW  - genetically deficient mice
PY  - 2012
AB  - Monoclonal antibodies (mAbs) and fusion proteins directed towards cell surface targets make an important contribution to the treatment of disease. The purpose of this review was to correlate the clinical and preclinical data on the 15 currently approved mAbs and fusion proteins targeted to the cell surface. The principal sources used to gather data were: the peer reviewed Literature; European Medicines Agency ?Scientific Discussions?; and the US Food and Drug Administration ?Pharmacology/Toxicology Reviews? and package inserts (United States Prescribing Information). Data on the 15 approved biopharmaceuticals were included: abatacept; abciximab; alefacept; alemtuzumab; basiliximab; cetuximab; daclizumab; efalizumab; ipilimumab; muromonab; natalizumab; panitumumab; rituximab; tocilizumab; and trastuzumab. For statistical analysis of concordance, data from these 15 were combined with data on the approved mAbs and fusion proteins directed towards soluble targets. Good concordance with human pharmacodynamics was found for mice receiving surrogates or non-human primates (NHPs) receiving the human pharmaceutical. In contrast, there was poor concordance for human pharmacodynamics in genetically deficient mice and for human adverse effects in all three test systems. No evidence that NHPs have superior predictive value was found.
ER  - 

TY  - JOUR
TI  - Abstracts from the 27th Congress of The Scandinavian Society of Anaesthesiology and Intensive Care Medicine
JO  - Acta Anaesthesiologica Scandinavica
VL  - 47
IS  - s116
SN  - 9781405127837
UR  - https://doi.org/10.1111/j.1399-6576.2004.47s116abs.x
DO  - doi:10.1111/j.1399-6576.2004.47s116abs.x
SP  - 1
EP  - 122
PY  - 2003
ER  - 

TY  - JOUR
TI  - PARKINSONISM I
JO  - Movement Disorders
VL  - 11
IS  - S1
SN  - 9781405127837
UR  - https://doi.org/10.1002/mds.1996.11.s1.113
DO  - doi:10.1002/mds.1996.11.s1.113
SP  - 113
EP  - 148
PY  - 1996
ER  - 
